PPAR Gamma Polyclonal antibody (16643-1-AP)
PPARG; NR1C3; Peroxisome proliferator-activated receptor gamma; PPAR-gamma; PPARγ
用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| Positive WB detected in | K-562 cells, HL-60 cells, mouse heart tissue, MCF-7 cells, U-937 cells |
| Positive IP detected in | HL-60 cells |
| Positive IHC detected in | human prostate cancer tissue, human breast cancer tissue, human colon cancer tissue, human placenta tissue, human thyroid cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | rat liver tissue |
| Positive FC (Intra) detected in | HeLa cells |
推荐稀释说明
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. Sample-dependent, Check data in validation data gallery.
详细信息
背景信息
Peroxisome Proliferator-Activated Receptors (PPARs) are ligand-activated intracellular transcription factors, members of the nuclear hormone receptor superfamily (NR), that includes estrogen, thyroid hormone receptors, retinoic acid, Vitamin D3 as well as retinoid X receptors (RXRs). The PPAR subfamily consists of three subtypes encoded by distinct genes denoted PPARα (NR1C1), PPARβ/δ (NR1C2) and PPARγ (NR1C3), which are activated by selective ligands. PPARγ, also named as PPARG, contains one nuclear receptor DNA-binding domain and is a receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. It plays an important role in the regulation of lipid homeostasis, adipogenesis, ins resistance, and development of various organs. Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) and may be associated with susceptibility to obesity. Defects in PPARG can lead to type 2 ins-resistant diabetes and hypertension. PPARG mutations may be associated with colon cancer. Genetic variations in PPARG are associated with susceptibility to glioma type 1 (GLM1). PPARG has two isoforms with molecular weight 57 kDa and 54 kDa (PMID: 9831621), but modified PPARG is about 67 KDa (PMID: 16809887). PPARG2 is a splice variant and has an additional 30 amino acids at the N-terminus (PMID: 15689403). Experimental data indicate that a 45 kDa protein displaying three different sequences immunologically related to the nuclear receptor PPARG2 is located in mitochondria (mt-PPAR). However, the molecular weight of this protein is clearly less when compared to that of PPARG2 (57 kDa) (PMID: 10922459). PPARG has been reported to be localized mainly (but not always) in the nucleus. PPARG can also be detected in the cytoplasm and was reported to possess extra-nuclear/non-genomic actions (PMID: 17611413; 19432669; 14681322).
文献引用 (185)
Axin formation inhibitor 1 aggravates hepatic ischemiaâreperfusion injury by promoting the ubiquitination and degradation of PPARβ.
Axin 形成抑制剂 1 通过促进 PPARβ 的泛素化和降解来加重肝脏缺血再灌注损伤
FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise.
富含 FNDC5/irisin 的 sEV 与骨靶向适体结合可缓解骨质疏松症:一种潜在的运动替代方案
N-Lactoyl-Phenylalanine modulates lipid metabolism in microglia/macrophage via the AMPK-PGC1α-PPARγ pathway to promote recovery in mice with spinal cord injury.
N-乳酰苯丙氨酸通过 AMPK-PGC1α-PPARα 通路调节小胶质细胞/巨噬细胞的脂质代谢,从而促进脊髓损伤小鼠的恢复
YTHDC1 promotes postnatal brown adipose tissue development and thermogenesis by stabilizing PPARγ
YTHDC1通过稳定PPARγ促进出生后棕色脂肪组织发育和产热。
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity
PTGR2抑制剂的发现有望成为治疗糖尿病和肥胖症的新策略
A novel human specific lncRNA MEK6-AS1 regulates adipogenesis and fatty acid biosynthesis by stabilizing MEK6 mRNA
一种新的人类特异性 lncRNA MEK6-AS1 通过稳定 MEK6 mRNA 来调节脂肪生成和脂肪酸生物合成
Harnessing engineered exosomes as METTL3 carriers: Enhancing osteogenesis and suppressing lipogenesis in bone marrow mesenchymal stem cells for postmenopausal osteoporosis treatment
利用工程化外泌体作为METTL3载体:增强骨髓间充质干细胞的成骨作用并抑制脂肪生成,用于治疗绝经后骨质疏松症
A bioactive three-layered skin substitute based on ECM components effectively promotes skin wound healing and regeneration
一种基于细胞外基质成分的生物活性三层皮肤替代物能有效促进皮肤伤口愈合和再生。
CILP1 interacting with YBX1 promotes hypertrophic scar formation by suppressing PPARs transcription
CILP1与YBX1相互作用,通过抑制PPARs转录促进肥厚性瘢痕形成。
Targeting NAMPT-OPA1 for treatment of senile osteoporosis
靶向NAMPT-OPA1治疗老年性骨质疏松症
- 1
- 2
- 3
- 4
- 5
- 6
- 19